Source:The Lancet Infectious Diseases
Author(s): Victoria Wells, Laura J V Piddock
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2jiy6m4
via IFTTT
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Tracheostomy is commonly performed life saving procedure. Organophosphorus compound poisoning is a very common emergency encountered in rural area where major population consists of agricultural workers. Ideal timing of tracheostomy is still controversial. Aim of the study is to assess the advantage of performing early (48 h–7 days) versus late tracheostomy (8–15 days) with regard to weaning from a ventilator, complications and length of hospital stay. This is a comparative retrospective interventional study in which 100 patients of organophosphorus poisoning who underwent tracheostomy during hospital stay due to prolonged intubation were analyzed. Study subjects were divided into two groups. Each group constitute of 50 patients each. Group A: Early tracheostomy (48 h–7 days) and Group B: Late tracheostomy (8–15 days). Early tracheostomy required a shorter duration of mechanical ventilator support (4–5 days) when compared to late tracheostomy (5–8 days), p < 0.05 and early tracheostomy facilitate early weaning. There was high incidence of complications in late tracheostomy group as compare to early tracheostomy group. Duration of hospital stay was also longer in Group B (mean 40 days) as compare to Group A (mean 32 days) with p < 0.05. We concluded that, early tracheostomy was associated with shorter duration of mechanical ventilator support, it helps for early weaning, shorted intensive care unit and hospital stay as compare to late tracheostomy.
When Dr. Amelio Annese put out his shingle in 1957 after completing his service in the U.S. Navy and graduating from Tufts University and Tufts Dental School, he might not have known at the time that he was starting a family tradition of excellence in dentistry that would span in to the next century. But 60 years later, the Annese family is proudly carrying on his supreme legacy with the continuation of the dental practice in the same office at 106 Broadway, Revere.
To evaluate oral health related quality of life (OHQoL) in edentulous patients treated with immediately loaded implants in the maxilla.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2ys2wVM
via IFTTT
We describe the case of a 16-year-old female patient with micrognathia, temporomandibular joint (TMJ) ankylosis, and obstructive sleep apnea, who was treated with mandibular distraction osteogenesis (DO) combi...
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2AB20Gw
via IFTTT
Thyroid , Vol. 0, No. 0.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2yqJzmg
via IFTTT
Thyroid , Vol. 0, No. 0.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2AzGMIW
via IFTTT
Decades before his private practice, he was part of a three-man dental clinic on a Royal Air Force base in Scotland, practicing his trade on men who were gathering intelligence on the Russians. Drake retired in 1984 from the Navy a captain after 24 years of service and moved with his wife Mary to Buena Vista, having been introduced to the Spring Canyon Christian Fellowship by a fellow officer.
Surgical exposure to access mitral valve has been performed through various chambers in the heart like left atrium, right atrium and trans septal approach, through ascending aorta and left ventricle as well. Depending upon the surgical pathology, body habitus of the patient, and previous cardiac surgery, each approach has some advantages and disadvantages. This article reviews all the approaches and the surgical indications as well the advantages and disadvantages of the each approach.
Lung cancer is the commonest cause of death worldwide but unfortunately, most patients present in an advanced stage of the disease. The classification of lung cancer has evolved since the first WHO publication in 1981, and the present edition was published in March 2015. A major change in 2015 was the introduction of the new terms adenocarcinoma in situ and minimally invasive adenocarcinoma to describe early adenocarcinoma of lung and abolition of the previous term bronchioloalveolar carcinoma. Tumors with micropapillary pattern and those showing spread through alveolar spaces have significant clinical implications with an increased propensity for recurrence. Tissue specimens require proper fixation in 10% buffered formalin which is an essential but an often neglected basic step; proper fixation is a prerequisite for good immunohistochemistry (IHC) and molecular test outcomes. Needle core biopsies should be handled judiciously to ensure that sufficient material is prioritized for molecular studies which are needed to guide personalized treatment. The WHO 2015 classification recommends the use of a single squamous cell marker (p40, or CK5/6) and a single adenocarcinoma marker (TTF1, or napsin) to distinguish squamous cell carcinoma and adenocarcinoma in difficult biopsies. The non-committal designation of non-small cell lung carcinoma (NSCLC) is discouraged. The exciting ongoing research findings on molecular biology of lung cancer necessitate constant expansion of laboratory test menu. Testing and treating lung cancer patients with epidermal growth factor (EGFR) mutation and anaplastic lymphoma kinase (ALK) gene fusion is now a standard of care, and ROS1 has been approved recently. The updated guidelines from the College of American Pathologists (CAP) and approval notifications from the Federal Drug Authority (FDA) are invaluable to justify initiation of new tests by pathology laboratories. Recently, FDA has approved testing for programmed death ligand (PDL1) with 22C3 antibody by IHC and EGFR testing on plasma by a non-invasive liquid biopsy test approach. To conclude, a comprehensive pathology report is vital for staging, comparing outcomes, and developing better strategies for patient care in the future.
Publication date: October 2017
Source:Journal of Clinical Epidemiology, Volume 90
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2zywviq
via IFTTT
Publication date: October 2017
Source:Journal of Clinical Epidemiology, Volume 90
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2zOvEem
via IFTTT
Publication date: Available online 28 October 2017
Source:Journal of Clinical Epidemiology
Author(s): Petra Schnell-Inderst, Theresa Hunger, Annette Conrads-Frank, Marjan Arvandi, Uwe Siebert
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2zyxXB2
via IFTTT
Publication date: December 2017
Source:Operative Techniques in Otolaryngology-Head and Neck Surgery, Volume 28, Issue 4
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2i2OS5q
via IFTTT
Project Rose Team: Gary Baxter, Dr. Rebecca Lauck, Dr. Brandon Hedgecock, Isiah Robertson, Dr. Harry Sugg, D. Gergen, Dr. Ed Hobbs, Eric Dickerson
As a country, we have satisfaction in being American, but each community also value's their own individual cultures. The American Sleep and Breathing Academy (ASBA) wants to release an official statement of support and pride for the communities in Florida and surrounding areas as well as Houston communities effected by Hurricane Harvey and Hurricane Irma. With different disasters in different areas come different recoveries but, nevertheless, recovery is inevitable.
The resilience of the communities damaged are stunning and marvelous, but not shocking. It is especially magnificent to see Houston rally behind the Houston Astros, major league contenders for the championship of America's pastime, and NFL legend/Rose of Texas Earl Campbell's Project Rose, a project dedicated to enhancing the safety of sports and improving sleep and wellness in communities throughout the country. After the devastating hurricane, Earl Campbell and Gary Baxter wanted to focus on adding to the local economy in Houston. They are doing so by launching sleep and wellness programs in 17 hospitals/clinics throughout Houston.
The wellness program is designed with an emphasis on preventive care and a healthier lifestyle. An ounce of prevention can save a pound of problems. That's why Project Rose Wellness Program is proudly offering the next generation of innovative lab testing, food/nutrition education, mental and physical health exercises, and providing a unique approach to understanding everyone's lifestyle requirements for better health.
Strengthening the ties of communities adds to the fortitude and unity of the entire country. The American Sleep and Breathing Academy thanks everyone involved for their contribution and unwavering capacity to recover quickly from difficult times.
Call David Gergen at 602-478-9713 to see how you can become involved.
Yorgo Foods Inc of Manchester NH, is recalling select varieties of Hommus and Baba Ghannouj, because they have the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2hhY0Cq
via IFTTT
Laryngo-Rhino-Otol
DOI: 10.1055/s-0043-121343
Georg Thieme Verlag KG Stuttgart · New York
Article in Thieme eJournals:
Table of contents | Full text
Annuloaortic ectasia with ascending aortic aneurysm with severe aortic regurgitation with severe left ventricular dysfunction is a serious condition especially in patients with Marfan syndrome (MFS) simultaneously having severe pectus excavatum (PE) deformity. We report our left parasternal approach in such patient in whom median sternotomy was not feasible. We achieved excellent exposure of dislocated heart and great vessels enabling Bentall procedure. Since patient did not consent for combined correction of chest wall deformity, we plan to undertake it later. Therefore, we conclude that left parasternal approach is feasible for standard aortic root replacement surgery in severe PE.
Mitral valve disease is a growing clinical problem. Surgical mitral valve repair and replacement remains the treatment of choice with excellent long-term clinical outcomes. However, a large number of symptomatic patients were deemed too high-risk undergoing surgical correction. Catheter-based technology has been in development to address this unmet need. Transcatheter mitral valve replacement devices are such technology and are currently undergoing clinical investigation. A systematic overview is being presented in the article.
To compare the mechanical resistance of conventional plates with a modified Y-plate in mandibular condyle fracture.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2zyZAb7
via IFTTT
In a previous pilot study we observed that intra-operative narrow-band imaging (NBI) helps achieve clear superficial resection margins. The aim of this study was to verify if the use of intra-operative NBI can help to obtain tailored resections and if it is influenced by the lesion site, aspects not investigated in our previous study.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2jglNH8
via IFTTT
There has been a growing shift towards endoscopic management of laryngeal procedures in pediatric otolaryngology. There still appears to be a shortage of pediatric otolaryngology programs and children's hospitals worldwide where physicians can learn and practice these skills. Laryngeal simulation models have the potential to be part of the educational training of physicians who lack exposure to relatively uncommon pediatric otolaryngologic pathology.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2iLhWxM
via IFTTT
To evaluate the type and severity of hearing impairment in pediatric patients with primary ciliary dyskinesia (PCD) and relate these measures to patient demographics, treatment options, and other otologic factors.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2zBqtLU
via IFTTT
To introduce in-continuity neck dissection (ND) in squamous cell carcinoma of the buccal mucosa (BMSCC) and to determine its impact on the oncologic outcomes of these patients.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2hrGFKN
via IFTTT
Clinical prediction models that support treatment decisions are usually evaluated for their ability to predict the risk of an outcome rather than treatment benefit – the difference between outcome risk with versus without therapy. We aimed to define performance metrics for a model's ability to predict treatment benefit.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2i19ECm
via IFTTT
NFL Legend Eric Dickerson, David Gergen, Dr. Harry Sugg
When considering the political/NFL ties the American Sleep and Breathing Academy (ASBA) holds, value in being a member and advantages over non-members certainly becomes apparent. However, that isn't the only reason the ASBA has become the fastest growing academy in the field of dental sleep medicine. Under the direction of David Gergen, the academy really focuses on a multidisciplinary approach. Having worked for pioneers in orthodontics and dental sleep medicine, David understands what we as dentists treating OSA need to be successful which translates to an overall improvement on patient outcomes and industry advances. Simply putting it, we have an academy fighting on our behalf.
Since 2012, the ASBA has had representatives of the academy meet in Washington D.C. with senators, congressmen and legislatures in charge of rulemaking relating to our field. Oral appliance therapy hasn't been properly recognized as a legitimate treatment option; in my humble opinion the ASBA is about to change all of that. The medical profession has never been truly educated on oral appliance therapy and achieving level ground starts with us dentists obtaining the best possible education.
For example, in our industry we have a very disappointing situation occurring with large companies who grew off the backs of trained and established sleep dentists hiring kids right out of school with no sleep experience and providing a measly nine hours of online education and calling them experts. Our industry has been undermined enough. Dr. Elliott Alpher was first to tell me, "The ASBA is the only sleep academy fighting for the dentists' rights in the OSA arena. The efforts will become stronger as the ASBA grows. The more members we have the more firepower we'll have. I am so pleased that I have joined this academy." I urge any dentist who is interested in sleep medicine to join the ASBA like I did and stand proud.
-Dr. Harry Sugg, DDS
With the rising cost of medical treatment, it makes a lot of sense to have some type of health coverage, regardless of age and status in life. When shopping for health insurance, it's important to know a few important things about it first.
Publication date: March 2018
Source:Calphad, Volume 60
Author(s): Hasan S. AlMatrouk, Viorel Chihaia, Valentin Alexiev
This paper focuses primarily on the P-T phase diagram determination by considering six polymorphs of magnesium hydride (α - rutile TiO2, P42/mnm, β - cubic modified CaF2, Pa3¯, γ - orthorhombic PbO2, Pbcn, δ' - orthorhombic, Pbca and cubic - Fm3¯m). The Gibbs free energy and other thermodynamic properties were evaluated by DFT-based thermodynamic calculations, within the frame of the quasi-harmonic approximation, for the pressure range 0–10GPa and temperatures between 0 and 1200K. Furthermore, the structural, energetic, and electronic properties of the investigated structures are conversed.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2jhaQF8
via IFTTT
Publication date: March 2018
Source:Calphad, Volume 60
Author(s): Axel van de Walle
The CALPHAD framework is built on assumption that all phases have a well-defined free energy over all accessible composition, temperature and pressure conditions. Unfortunately, it is common for phases to exhibit mechanical instabilities in at least some range of conditions, thus precluding direct experimental measurements and hindering computational efforts. A pragmatic solution has often been to extrapolate free energies from stable region into the unstable regions, but extrapolations from different systems that share a common phase may not agree and extrapolated free energies can unintentionally lie below the free energy of stable phases. Computational approaches that aim to directly calculate the free energy of unstable phases offer a promising avenue to address these issues. Among them, the recently proposed "inflection detection" scheme lies on a strong theoretical footing. We provide further support for this approach by demonstrating that it yield free energies that agree very well with the widely used SGTE (Scientific Group Thermodata Europe) data for pure elements. This finding suggest that it may be possible to get the best of both worlds: obtain a theoretically justified definition of the free energy of mechanically unstable phases and preserve much of existing empirical standards for the assignments of such free energies.
Publication date: Available online 10 November 2017
Source:Diagnostic Microbiology and Infectious Disease
Author(s): Andreza Faria Martins, Larissa Bail, Carmen Antonia Sanches Ito, Keite da Silva Nogueira, Tanise Vendruscolo Dalmolin, Amanda Silva Martins, Jaime Luis Lopes Rocha, Alisa W. Serio, Felipe Francisco Tuon
BackgroundPlazomicin is a next-generation aminoglycoside with activity against Enterobacteriaceae, including carbapenemase-producing Enterobacteriaceae (CPE).ObjectiveThe aim of this study was to evaluate the activity of plazomicin against CPE (Klebsiella spp., E. coli, Serratia spp., Enterobacter spp., Citrobacter spp., Morganella spp., Proteus spp., Providencia spp.) from different Brazilian hospitals.MethodsA total of 4000 carbapenem-resistant Enterobacteriaceae isolates were collected from clinical samples in 50 Brazilian hospitals during 2013–2015. Of these, 499 carbapenem-resistant isolates (CLSI criteria) were selected for further evaluation via broth microdilution to assess for the activity of plazomicin, colistin, tigecycline, meropenem, amikacin and gentamicin. Additionally, the isolates were assessed for the presence of carbapenemase genes (blaKPC, blaNDM, blaOXA-48-like, blaIMP, blaBKC, blaGES and blaVIM) by polymerase chain reaction (PCR). When PCR was positive to blaOXA-48-like, blaIMP, blaGES and blaVIM, the carbapenemase genes were sequenced.ResultsblaKPC was the most prevalent carbapenemase gene found (n=397), followed by blaNDM (n=81), blaOXA-48 (n=12) and blaIMP-1 (n=3). Other genes were identified in only one isolate each: blaBKC-1, blaGES-16, blaGES-1, blaOXA-370, blaVIM-1. One isolate had two carbapenemase genes (blaKPC and blaNDM). 33% of the isolates were non-susceptible to colistin, 24% to tigecycline, 97% to meropenem, 50% to amikacin and 82% to gentamicin (via EUCAST criteria). The plazomicin MIC50/90 was 0.5/ ≥ 64mg/L, with 84% of MICs ≤2mg/L and 87% of MICs ≤4mg/L. Elevated MICs to plazomicin were not associated with a specific carbapenemase or bacterial species.ConclusionThe MICs of plazomicin against CPE were lower than that of other aminoglycosides. Plazomicin is a promising drug for the treatment of CPE infections.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2zAdqKG
via IFTTT
Publication date: Available online 10 November 2017
Source:Journal of Epidemiology and Global Health
Author(s): K.E. Mues, M. Klein, D.G. Kleinbaum, W.D. Flanders, L.M. Fox
Episodes of adenolymphangitis (ADL) are a recurrent clinical aspect of lymphatic filariasis (LF) and a risk factor for progression of lymphedema. Inter-digital entry lesions, often found on the web spaces between the toes of those suffering from lymphedema, have been shown to contribute to the occurrence of ADL episodes. Use of antifungal cream on lesions is often promoted as a critical component of lymphedema management.Our objective was to estimate the observed effect of antifungal cream use on ADL episodes according to treatment regimen among a cohort of lymphedema patients enrolled in a morbidity management program. We estimated this effect using marginal structural models for time varying confounding.In this longitudinal study, we estimate that for every one-unit increase in the number of times one was compliant to cream use through 12 months, there was a 23% (RR = 0.77 (0.62, 0.96)) decrease in the number of ADL episodes at 18 months, however the RR's were not statistically significant at other study time points. Traditionally adjusted models produced a non-significant RR closer to the null at all time points.This is the first study to estimate the effect of a regimen of antifungal cream on the frequency of ADL episodes. This study also highlights the importance of the consideration and proper handling of time-varying confounders in longitudinal observational studies.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2zNfyS3
via IFTTT
Two members of the American Sleep and Breathing Academy are calling on their fellow dental sleep specialists to ask their own Senators to support a bill that would bring regulatory certainty to the diagnosis and treatment of deadly obstructive sleep apnea among transportation workers. OSA has been a factor in several recent rail and bus and truck accidents.
However, the bill is stalled in a committee and needs help from constituents to move it forward before Congress adjourns in December. That's why Drs. Elliott Alpher and Neal Seltzer are calling on their fellow ASBA members to take action by contacting their own Senators to ask that the bill passed out of committee. To streamline the process, please use the toolkit, which contains a sample phone script and letter to your senator. Here is a toolkit to make the outreach by phone or letter easier.
The toolkit consists of a phone script and a letter, which can be easily personalized. Members are asked to call during November to move the bill to action before the end of the year. It would be especially helpful to call Committee Members that have jurisdiction over the measure.
On October 26, 2017, Drs. Elliott Alpher and Neal Seltzer met with representatives of Senator Cory Booker (D- NJ), Senator Kirstin Gillibrand (D-NY) and Senator Debbie Stabenow (D- MI).
ASBA member Richard Klein worked behind the scenes to arrange the meeting with Stabenow who is a member of the influential budget and finance committees.
"We need to reach each member of the Senate," Dr. Neal Seltzer said." We have met with four so far. With the help of the membership, we can contact all the senators."
During their Senate meetings, Drs. Alpher and Seltzer explained the need to have a dental sleep expert appointed to the Medical Review Board. This body sets health guidelines, including the diagnosis and treatment of OSA for transportation workers. Currently there are no sleep medical experts among the five members.
The staffers were especially interested in a letter Dr. Alpher received from the FMCSA in response to his letter to Department of Transportation Secretary Elaine Chao. FMCSA Associate Administrator for Policy, Larry Minor, responded that the agency had decided the current methods of diagnosing and treating OSA among transportation workers are "adequate."
Drs. Alpher and Seltzer also volunteered to provide medical and scientific expertise to the Senators as the legislation works its way through the process.
"In all three offices, we were well received," said Dr. Alpher. "They were genuinely interested in willing to follow-through on our offers to help them gain some certainty for transportation workers."
TOOLKIT
The Honorable <Full Name>
United States Senate
NUMBER BUILDING
Washington, DC <ZIP>
Dear Senator <NAME>:
My name is <Your Name> and I am one of your constituents and I live in <Your City>.
I am writing to ask for your support for the Senate Bill –– S.1883, to require the Department of Transportation to finish the rule for obstructive sleep apnea diagnosis and treatment among transportation workers.
The importance of safety for both the traveling public and the individual transportation workers cannot be overstated. It seems every day, there is a news report of another fatal accident caused by obstructive sleep apnea. But we need federal uniformity for both transportation workers and the traveling public. There's a bill that's languishing right now in committee and I ask you to support its passage. S-1883 will compel the Department of Transportation to finish the work on a rule that will provide for testing and treatment of obstructive sleep apnea among the nation's truckers and rail workers.
Without federal certainty, people are dying. The National Transportation Safety Board ruled recently that obstructive sleep apnea was to blame for two rail accidents.
Under the current guidelines transportation workers face even more confusing, contradictory and costly for the workers. The Medical Review Board, which sets the standards and trains the certified medical examiners to conduct physicals, has no dental sleep medicine or other sleep professional among its members. We need a dental sleep medical specialist appointed to that board.
There is no one trained in the diagnosis and treatment of obstructive sleep apnea on the board and none of the certified medical examiners have experience in diagnosing the disease. In fact, drivers have said they often receive different results, depending upon the examiner. Then, drivers and railway workers face paying as much as $5,000 out-of-pocket for just one expensive treatment option that offers no guarantees of success.
Right now, as many as 18 million people are living undiagnosed. Those include railway operators and truck drivers, who are at higher risk because they lead more sedentary lives and maintain less regular sleep schedules.
Obstructive sleep apnea is a killer and if you know someone who snores, pay attention. Snoring is the body's warning sign that the person is not getting sufficient oxygen and is at risk for obstructive sleep apnea. It is linked to so many life-threatening diseases such as heart attacks, strokes, high blood pressure, type 2 diabetes, depression, Alzheimer's Disease and even glaucoma. I know you would agree that anything we can do to improve the health and safety of the traveling public and transportation workers is beneficial to all.
I am asking that you call for S.1883 to be advanced in the SURFACE TRANSPORTATION AND MERCHANT MARINE INFRASTRUCTURE, SAFETY AND SECURITY subcommittee.
Thank you for your time and consideration.
Sincerely,
<YOUR NAME>
Phone Script in Support of Senate Bill –– S.1883, to require the Department of Transportation to finish the rule for obstructive sleep apnea diagnosis and treatment among transportation workers
Thank you for taking my call. My name is <Your Name> and I live in <Your City>.
I am one of your constituents.
Thank you for your time and consideration.
The chronic use of benzodiazepines and benzodiazepine-related drugs (BZ/Z) in older people is common and not without risks. The objective of this study was to evaluate whether the implementation of a clinical rule promotes the discontinuation of chronically used BZ/Z for insomnia.
A clinical rule, generating an alert in case of chronic BZ/Z use, was created and applied to the nursing home (NH) setting. The clinical rule was a one-off intervention, and alerts did not occur over time. Reports of the generated alerts were digitally sent to NH physicians with the advice to phase out and eventually stop the BZ/Z. In cases where the advice was adopted, a follow-up period of 4 months on the use of BZ/Z was taken into account in order to determine whether the clinical rule alert led to a successful discontinuation of BZ/Z.
In all, 808 NH patients were screened. In 161 (19.1%) of the patients, BZ/Z use resulted in a clinical rule alert. From these, the advice to phase out and stop the BZ/Z was adopted for 27 patients (16.8%). Reasons for not following the advice consisted of an unsuccessful attempt in the past (38 patients), patients family and/or patient resistance (37 patients), the non-continuous use of BZ/Z (32 patients) and indication still present (27 patients). Of the 12 NH physicians, seven adopted the advice.
The success rate of a clinical rule for discontinuation of chronically used BZ/Z for insomnia was low, as reported in the present study. Actions should be taken to help caregivers, patients and family members understand the importance of limiting BZ/Z use to achieve higher discontinuation rates.
Ministry of Health data shows the percentage of Kiwi 5-year-olds found to have rotten teeth at community dental clinics decreased from 49 per cent in 2001 to 40 per cent in 2016. During the same period, children aged 0 to 14 years old requiring general anaesthetic for rotten teeth removal increased from 4500 to 7500 , according to ministry data.
Previous studies reported that lncRNA antisense non-coding RNA in the INK4 locus (ANRIL) was upregulated in hepatocellular carcinoma (HCC) tissues and decreased expression of ANRIL could suppress cell proliferation, metastasis, and invasion and induce apoptosis of HCC cells. However, the molecular mechanism of ANRIL involved in HCC tumorigenesis is still unknown.
The expressions of ANRIL and miR-122-5p in HCC tissues and cells were quantified by qRT-PCR. MTT assay, colony formation assay, wound healing assay, and transwell invasion assay were performed to evaluate cell growth, metastasis, and invasion, respectively. RNA immunoprecipitation (RIP) assay and luciferase reporter assay were performed to determine whether ANRIL could directly bind to miR-122-5p in HCC cells. Xenograft tumor experiment was conducted to confirm the biological role and underlying mechanism of ANRIL in vivo.
The results showed that ANRIL was upregulated and miR-122-5p was downregulated in HCC tissues and cells. ANRIL was negatively correlated with miR-122-5p expression in HCC tissues. Knockdown of ANRIL or miR-122-5p overexpression suppressed HCC cell viability, colony formation ability, metastasis, and invasion. ANRIL was demonstrated to directly bind to miR-122-5p and inhibit its expression. Forced expression of ANRIL abolished the inhibitory effect of miR-122-5p overexpression on HCC progression. In vivo experiment demonstrated that ANRIL knockdown impeded tumor growth in vivo and increased miR-122-5p expression.
Our finding suggested that knockdown of ANRIL suppressed cell proliferation, metastasis and invasion via regulating miR-122-5p expression in HCC, illustrating the underlying mechanism of the oncogenic role of ANRIL in HCC.
Vocal fold augmentation by injection of autologous fascia has been used since the 1990s with excellent safety record in 500 operations done under general anaesthesia. It is safe from risks arising from allergic or other foreign body adverse reactions. Fascia provides long-term augmentation and remains stable 3-10 years after injection.
Vocal fold augmentation under local anaesthesia is excellent alternative for those unfit for general anaesthesia, providing aid to fragile and weak persons with vocal fold paralysis. However, all of available synthetic materials resorb within 6-24 months.
Fascia injection under local anaesthesia provides the possibility for a long-term vocal fold medialization while avoiding risk of general anaesthesia. Fascia lata harvesting and processing is easily done (as shown in video) followed by injection into the vocal fold. The whole procedure is done under local anaesthesia. Procedure offers long-term vocal fold medialization, fine tuning the amount of the medialization by immediate feedback from the patient's voice. Operation time is one hour.
This article is protected by copyright. All rights reserved.
Anti-beta-2-glycoprotein I antibodies (anti-β2GPI) which are the main antiphospholipid antibodies that characterize the autoimmune "antiphospholipid syndrome" are pathogenic and are contributing to thrombosis. We aimed to evaluate the presence and the diagnostic importance of these antibodies in children with different rheumatologic diseases with or without thrombosis risk. A total of 100 children with different rheumatologic diseases evaluated retrospectively. The mean anti-β2GPI IgG (p = 0.108), IgA (p = 0.547), and IgM (p = 0.807) levels showed no statistically significant difference between different diagnosis groups. But anti-β2GPI IgA and IgM levels were higher in SLE patient group. The mean anti-β2GPI IgG (p = 0.375), IgA (p = 0.811), and IgM (p = 0.276) levels were not also showed difference between disease groups with/without predisposition to thrombosis even though concentrations were higher in thrombosis group. In children with rheumatological complaints, anti-β2GPI antibody measurements should not be the first diagnostic criteria if vasculitis is not thought as the primary defect underlying the clinical symptoms.